Globavir - logo

Globavir - Company & Market Research Reports

Chikungunya (CHIKV) Infection Drug Development Pipeline Study, H2 2018 - Product Thumbnail Image

Chikungunya (CHIKV) Infection Drug Development Pipeline Study, H2 2018

  • Report
  • 90 Pages
From
Deep Learning in Drug Discovery and Diagnostics, 2017 - 2035 - Product Thumbnail Image

Deep Learning in Drug Discovery and Diagnostics, 2017 - 2035

  • Report
  • 235 Pages
From
IDO Inhibitors - A Pipeline Analysis Report - Product Thumbnail Image

IDO Inhibitors - A Pipeline Analysis Report

  • Report
  • 70 Pages
From
C-X-C Chemokine Receptor Type 4 (Fusin or Leukocyte-Derived Seven Transmembrane Domain Receptor or Lipopolysaccharide-Associated Protein 3 or Stromal Cell-Derived Factor 1 Receptor or CD184 or CXCR4) - Pipeline Review, H1 2016 - Product Thumbnail Image

C-X-C Chemokine Receptor Type 4 (Fusin or Leukocyte-Derived Seven Transmembrane Domain Receptor or Lipopolysaccharide-Associated Protein 3 or Stromal Cell-Derived Factor 1 Receptor or CD184 or CXCR4) - Pipeline Review, H1 2016

  • Report
  • 116 Pages
From
Chikungunya Fever - Pipeline Review, H1 2018 - Product Thumbnail Image

Chikungunya Fever - Pipeline Review, H1 2018

  • Report
  • 100 Pages
From
Dengue Fever - Pipeline Review, H2 2017 - Product Thumbnail Image

Dengue Fever - Pipeline Review, H2 2017

  • Report
  • 166 Pages
From
Dengue Fever - Pipeline Review, H1 2017 - Product Thumbnail Image

Dengue Fever - Pipeline Review, H1 2017

  • Report
  • 170 Pages
From
CCR4 Inhibitor -Pipeline Insight, 2018 - Product Thumbnail Image

CCR4 Inhibitor -Pipeline Insight, 2018

  • Drug Pipelines
  • 60 Pages
From
Programmed Cell Death Protein 1 (CD279 or Systemic Lupus Erythematosus Susceptibility 2 or PD1) - Pipeline Review, H1 2016 - Product Thumbnail Image

Programmed Cell Death Protein 1 (CD279 or Systemic Lupus Erythematosus Susceptibility 2 or PD1) - Pipeline Review, H1 2016

  • Report
  • 181 Pages
From
Ebola Viral Infections - Pipeline Review, H1 2016 - Product Thumbnail Image

Ebola Viral Infections - Pipeline Review, H1 2016

  • Report
  • 282 Pages
From
Ebola Viral Infections - Pipeline Review, H2 2015 - Product Thumbnail Image

Ebola Viral Infections - Pipeline Review, H2 2015

  • Report
  • 235 Pages
From
C-X-C Chemokine Receptor (CXCR) Inhibitors - Competitive Landscape, Market and Pipeline Analysis, 2018 - Product Thumbnail Image

C-X-C Chemokine Receptor (CXCR) Inhibitors - Competitive Landscape, Market and Pipeline Analysis, 2018

  • Drug Pipelines
  • 139 Pages
From
CXCR4 Inhibitor -Pipeline Insight, 2018 - Product Thumbnail Image

CXCR4 Inhibitor -Pipeline Insight, 2018

  • Drug Pipelines
  • 90 Pages
From
C-X-C Chemokine Receptor Type 4 - Pipeline Review - Product Thumbnail Image

C-X-C Chemokine Receptor Type 4 - Pipeline Review

  • Report
  • 108 Pages
From
Dengue Fever Global Clinical Trials Review, H2, 2017 - Product Thumbnail Image

Dengue Fever Global Clinical Trials Review, H2, 2017

  • Clinical Trials
  • 105 Pages
From
Connexin (Gap Junction Protein) - Pipeline Review, H2 2016 - Product Thumbnail Image

Connexin (Gap Junction Protein) - Pipeline Review, H2 2016

  • Report
  • 43 Pages
From
C-C Chemokine Receptor Type 4 (C-C CKR-4 or K5-5 or CD194 or CCR4) - Pipeline Review, H1 2016 - Product Thumbnail Image

C-C Chemokine Receptor Type 4 (C-C CKR-4 or K5-5 or CD194 or CCR4) - Pipeline Review, H1 2016

  • Report
  • 45 Pages
From
Globavir Biosciences, Inc Company Profile - Outlook, Business Segments, Competitors, Goods and Services, SWOT and Financial Analysis - Product Thumbnail Image

Globavir Biosciences, Inc Company Profile - Outlook, Business Segments, Competitors, Goods and Services, SWOT and Financial Analysis

  • Company Profile
  • 30 Pages
From
  • 18 Results (Page 1 of 1)
Loading Indicator
adroll